BLTE
Belite Bio·NASDAQ
--
--(--)
--
--(--)
BLTE fundamentals
Belite Bio (BLTE) released its earnings on Mar 2, 2026: revenue was 0 (YoY --), met estimates; EPS was -0.38 (YoY -18.75%), beat estimates.
Revenue / YoY
0
--
EPS / YoY
-0.38
-18.75%
Report date
Mar 2, 2026
BLTE Earnings Call Summary for Q4,2025
- **FDA NDA submission Q2 2026; 36% lesion growth reduction vs. placebo, 72-75 subjects enrolled in DRAGON II.
EPS
Revenue
Revenue & Expenses
Key Indicators
Belite Bio (BLTE) key financial stats and ratios, covering profitability, financial health, and leverage.
Belite Bio (BLTE)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Belite Bio (BLTE)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Belite Bio (BLTE)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Belite Bio (BLTE) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Belite Bio (BLTE) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What were the key takeaways from Belite Bio's earnings call?What is Belite Bio's gross profit margin?What were the key takeaways from Belite Bio’s earnings call?What does Belite Bio do and what are its main business segments?What guidance did Belite Bio's management provide for the next earnings period?What is the revenue and EPS growth rate for Belite Bio year over year?What is Belite Bio's latest dividend and current dividend yield?What factors drove the changes in Belite Bio's revenue and profit?
